Gena Wang Analyst PerformanceManaging Director, Biotech Equity Research at BarclaysGena Wang is a stock analyst at Barclays in the medical sector, covering 26 publicly traded companies. Over the past year, Gena Wang has issued 56 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Gena Wang's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Gena Wang's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings134 Last 11 YearsBuy Recommendations63.43% 85 Buy RatingsCompanies Covered26 Unique Companies Ratings Distribution134RatingsDistribution of strong buy, buy, hold, and sell ratings by Gena Wang.RatingPercentageCount Strong Buy0.7%1 ratings Buy62.7%84 ratings Hold29.1%39 ratings Sell7.5%10 ratingsOut of 134 total stock ratings issued by Gena Wang at Barclays, the majority (62.7%) have been Buy recommendations, followed by 29.1% Hold, 7.5% Sell, and 0.7% Strong Buy.Best & Worst CallsBest Call0000.0%ALNYDec 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%OVASMar 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ26 companiesGena Wang, an analyst at Barclays, currently covers 26 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical26 companies100.0%Gena Wang of Barclays specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE22 companies84.6%MED - DRUGS3 companies11.5%PHARMACEUTICAL PREPARATIONS1 company3.8% Gena Wang's Ratings History at Barclays Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsRGNXREGENXBIO5/15/2026Lower Price Target$6.24$12.00Overweight$0.0000.00% ROICYTKCytokinetics4/6/2026Boost Price Target$65.14$95.00Overweight$0.0000.00% ROICYTKCytokinetics4/2/2026Upgrade$65.48Strong-Buy$0.0000.00% ROIBMRNBioMarin Pharmaceutical3/3/2026Boost Price Target$59.74$105.00Overweight$0.0000.00% ROILEGNLegend Biotech2/4/2026Lower Price Target$16.58$80.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics1/28/2026Initiated Coverage$22.17$20.00Equal Weight$0.0000.00% ROIMRNAModerna1/28/2026Initiated Coverage$45.45$25.00Equal Weight$0.0000.00% ROIIONSIonis Pharmaceuticals1/28/2026Initiated Coverage$82.14$95.00Overweight$0.0000.00% ROICYTKCytokinetics1/28/2026Initiated Coverage$64.01$87.00Overweight$0.0000.00% ROIBMRNBioMarin Pharmaceutical1/28/2026Initiated Coverage$56.85$80.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ALNYAlnylam Pharmaceuticals1/28/2026Initiated Coverage$354.75$527.00Overweight$0.0000.00% ROIFDMT4D Molecular Therapeutics1/28/2026Initiated Coverage$8.49$33.00Overweight$0.0000.00% ROIVRTXVertex Pharmaceuticals1/27/2026Upgrade$474.17$606.00Overweight$0.0000.00% ROIRGNXREGENXBIO1/27/2026Initiated Coverage$13.41$37.00Overweight$0.0000.00% ROIPTCTPTC Therapeutics1/27/2026Upgrade$75.49$119.00Overweight$0.0000.00% ROICYTKCytokinetics12/22/2025Boost Price Target$62.72$87.00Overweight$0.0000.00% ROIRAREUltragenyx Pharmaceutical11/24/2025Lower Price Target$33.38$50.00Overweight$0.0000.00% ROILEGNLegend Biotech11/13/2025Lower Price Target$31.09$90.00Overweight$0.0000.00% ROIFDMT4D Molecular Therapeutics11/11/2025Lower Price Target$10.17$33.00Overweight$0.0000.00% ROISGMOSangamo Therapeutics11/7/2025Reiterated Rating$0.46$1.00Equal Weight$0.0000.00% ROIMRNAModerna11/7/2025Lower Price Target$23.56$25.00Equal Weight$0.0000.00% ROINTLAIntellia Therapeutics11/7/2025Lower Price Target$9.65$14.00Overweight$0.0000.00% ROIPTCTPTC Therapeutics11/5/2025Boost Price Target$67.72$68.00Equal Weight$0.0000.00% ROISRPTSarepta Therapeutics11/5/2025Lower Price Target$18.07$20.00Equal Weight$0.0000.00% ROIVRTXVertex Pharmaceuticals11/4/2025Boost Price Target$426.00$414.00Equal Weight$0.0000.00% ROISLDBSolid Biosciences11/4/2025Set Price Target$5.20$9.00Overweight$0.0000.00% ROIBCRXBioCryst Pharmaceuticals11/4/2025Lower Price Target$6.86$9.00Equal Weight$0.0000.00% ROIALNYAlnylam Pharmaceuticals10/31/2025Boost Price Target$448.14$527.00Overweight$0.0000.00% ROIIONSIonis Pharmaceuticals10/30/2025Boost Price Target$71.88$95.00Overweight$0.0000.00% ROINTLAIntellia Therapeutics10/28/2025Lower Price Target$14.79$24.00Overweight$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/28/2025Lower Price Target$52.67$80.00Overweight$0.0000.00% ROICLLSCellectis10/17/2025Boost Price Target$4.52$8.00Overweight$0.0000.00% ROICYTKCytokinetics10/6/2025Boost Price Target$56.97$82.00Overweight$0.0000.00% ROIKODKodiak Sciences9/25/2025Upgrade$15.49$17.00Equal Weight$0.0000.00% ROIIONSIonis Pharmaceuticals9/23/2025Boost Price Target$61.36$82.00Overweight$0.0000.00% ROIIONSIonis Pharmaceuticals9/3/2025Boost Price Target$60.44$78.00Overweight$0.0000.00% ROICYTKCytokinetics9/3/2025Boost Price Target$47.91$71.00Overweight$0.0000.00% ROIIONSIonis Pharmaceuticals8/22/2025Boost Price Target$43.24$58.00Overweight$0.0000.00% ROIKODKodiak Sciences8/14/2025Boost Price Target$8.62$7.00Underweight$0.0000.00% ROIRNAAvidity Biosciences8/8/2025Reiterated Rating$47.52$62.00Overweight$0.0000.00% ROIJune 12: $100 Turns Into $100,000? (Ad)The SpaceX IPO is scheduled for June 12, and former tech executive Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before major runs - says the window to get in early is closing fast. Brown is showing investors how to claim a stake in Elon Musk's company before it hits the public markets. Once the IPO happens, this pre-public opportunity disappears.Click here to see how to get ahead of the SpaceX IPORGNXREGENXBIO8/8/2025Lower Price Target$7.96$37.00Overweight$0.0000.00% ROICRSPCRISPR Therapeutics8/6/2025Boost Price Target$54.76$56.00Equal Weight$0.0000.00% ROIBEAMBeam Therapeutics8/6/2025Lower Price Target$17.86$21.00Equal Weight$0.0000.00% ROIMRNAModerna8/4/2025Lower Price Target$27.39$31.00Equal Weight$0.0000.00% ROIALNYAlnylam Pharmaceuticals8/1/2025Boost Price Target$392.24$460.00Overweight$0.0000.00% ROIPTCTPTC Therapeutics7/29/2025Boost Price Target$49.02$46.00Equal Weight$0.0000.00% ROISRPTSarepta Therapeutics7/29/2025Upgrade$17.42$22.00Equal Weight$0.0000.00% ROISRPTSarepta Therapeutics7/28/2025Downgrade$12.43Strong Sell$0.0000.00% ROISRPTSarepta Therapeutics7/27/2025Reiterated Rating$16.54Underweight$0.0000.00% ROISRPTSarepta Therapeutics7/22/2025Set Price Target$13.32$18.00Equal Weight$0.0000.00% ROISRPTSarepta Therapeutics7/22/2025Downgrade$13.61Underweight$0.0000.00% ROISRPTSarepta Therapeutics7/17/2025Boost Price Target$22.10$32.00Overweight$0.0000.00% ROIIONSIonis Pharmaceuticals7/1/2025Upgrade$39.51$57.00Overweight$0.0000.00% ROISRPTSarepta Therapeutics6/17/2025Lower Price Target$21.72$29.00Overweight$0.0000.00% ROIRNAAvidity Biosciences6/10/2025Boost Price Target$32.66$59.00Overweight$0.0000.00% ROIRNAAvidity Biosciences6/10/2025Boost Price Target$32.66$59.00Overweight$0.0000.00% ROISLDBSolid Biosciences5/16/2025Lower Price Target$2.87$10.00Overweight$0.0000.00% ROISGMOSangamo Therapeutics5/14/2025Lower Price Target$0.46$5.00Overweight$0.0000.00% ROICLLSCellectis5/13/2025Lower Price Target$1.42$4.00Overweight$0.0000.00% ROIFDMT4D Molecular Therapeutics5/9/2025Lower Price Target$3.26$38.00Overweight$00.0000.00% ROICRSPCRISPR Therapeutics5/9/2025Lower Price Target$37.20$42.00Equal Weight$00.0000.00% ROIPTCTPTC Therapeutics5/8/2025Lower Price Target$42.96$42.00Equal Weight$00.0000.00% ROIBCRXBioCryst Pharmaceuticals5/7/2025Boost Price Target$10.27$11.00Equal Weight$0.0000.00% ROIBEAMBeam Therapeutics5/7/2025Lower Price Target$15.92$25.00Equal Weight$00.0000.00% ROICYTKCytokinetics4/24/2025Initiated Coverage$38.00$55.00Overweight$00.0000.00% ROIVIRVir Biotechnology2/28/2025Boost Price Target$8.39$31.00Overweight$0.0000.00% ROINTLAIntellia Therapeutics2/28/2025Lower Price Target$10.09$26.00Overweight$00.0000.00% ROIMRNAModerna2/18/2025Downgrade$32.99$45.00Equal Weight$00.0000.00% ROICRSPCRISPR Therapeutics2/12/2025Boost Price Target$39.62$56.00Equal Weight$00.0000.00% ROIVRTXVertex Pharmaceuticals2/11/2025Boost Price Target$460.76$467.00Equal Weight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenCitigroupRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupEvercoreCanaccord Genuity GroupKeyCorpBerenberg BankSanford C. BernsteinShore Capital GroupWilliam BlairUBS GroupBarclays Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
